{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:28:08Z","timestamp":1794637688203,"version":"4.9.1"},"reference-count":27,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,11,11]],"date-time":"2008-11-11T00:00:00Z","timestamp":1226361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2009,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Some cases of T\u2010cell acute lymphoblastic leukaemia (ALL) express markers found in natural\u2010killer (NK) cells, such as CD56 and CD16. Out of 84 T\u2010cell ALL cases diagnosed at our Institution, CD56 and\/or CD16 was detected in 24 (28\u00b75%), which we designated T\/NK\u2010ALL group. Clinical features, laboratory characteristics, survival and expression of cytotoxic molecules were compared in T\/NK\u2010ALL and T\u2010ALL patients. Significant differences were observed regarding age (24\u00b79 vs. 16\u00b74\u2003years in T\/NK\u2010ALL and T\u2010ALL, respectively, <jats:italic>P\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>0\u00b7006) and platelet counts (177\u2003\u00d7\u200310<jats:sup>9<\/jats:sup>\/l vs. 75\u2003\u00d7\u200310<jats:sup>9<\/jats:sup>\/l in T\/NK\u2010ALL and T\u2010ALL, respectively, <jats:italic>P\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>0\u00b703). Immunophenotypic analysis demonstrated that CD34, CD45RA and CD33 were more expressed in T\/NK\u2010ALL patients, whereas CD8 and terminal deoxynucleotidyl transferase were more expressed in T\u2010ALL patients (<jats:italic>P\u2003<\/jats:italic>&lt;<jats:italic>\u2003<\/jats:italic>0\u00b705<jats:italic>)<\/jats:italic>. The mean overall survival (863 vs. 1869\u2003d, <jats:italic>P\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>0\u00b702) and disease\u2010free survival (855 vs. 2095\u2003d, <jats:italic>P\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>0\u00b7002) were shorter in patients expressing CD56\/CD16. However, multivariate analysis identified CD56\/CD16 as an independent prognostic factor only for DFS. Cytotoxic molecules were highly expressed in T\/NK\u2010ALL compared to T\u2010ALL. Perforin, granzyme B and TIA\u20101 were detected in 12\/17, 4\/17 and 7\/24 T\/NK\u2010ALL patients and in 1\/20, 0\/20 and 1\/20 T\u2010ALL respectively (<jats:italic>P\u2003<\/jats:italic>&lt;<jats:italic>\u2003<\/jats:italic>0\u00b7001, <jats:italic>P\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>0\u00b7036 and <jats:italic>P\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>0\u00b7054). Therefore, the presence of CD56\/CD16 was associated with distinct clinical features and expression of cytotoxic molecules in the blasts.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2008.07457.x","type":"journal-article","created":{"date-parts":[[2008,11,12]],"date-time":"2008-11-12T00:35:39Z","timestamp":1226450139000},"page":"223-229","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["The presence of CD56\/CD16 in T\u2010cell acute lymphoblastic leukaemia correlates with the expression of cytotoxic molecules and is associated with worse response to treatment"],"prefix":"10.1111","volume":"144","author":[{"given":"Leandro F. F.","family":"Dalmazzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael H.","family":"J\u00e1como","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 F.","family":"Marinato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena L.","family":"Figueiredo\u2010Pontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato L. G.","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aglair B.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo M.","family":"Rego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto P.","family":"Falc\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,12,17]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2257.2002.00135.x"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2003.11.003"},{"key":"e_1_2_6_4_1","first-page":"1783","article-title":"Proposals for the immunological classification of acute leukaemias. European Group for the Immunological Characterization of Leukaemias (EGIL)","volume":"9","author":"Bene M.C.","year":"1995","journal-title":"Leukaemia"},{"key":"e_1_2_6_5_1","first-page":"142","article-title":"Treatment results of three consecutive Brazilian cooperative childhood ALL protocols: GBTLI\u201080, GBTLI\u201082 and \u201085. ALL Brazilian Group","volume":"7","author":"Brandalise S.","year":"1993","journal-title":"Leukemia"},{"key":"e_1_2_6_6_1","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1182\/blood.V88.11.4265.bloodjournal88114265","article-title":"Hepatosplenic T\u2010cell lymphoma: a distinct clinico\u2010pathologic entity of cytotoxic \u03b3\u03b4 T\u2010cell origin","volume":"88","author":"Cooke C.B.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.60.070191.001103"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)62556-4"},{"key":"e_1_2_6_9_1","first-page":"1893","article-title":"TIA\u20101 expression in lymphoid neoplasms. Identification of subsets of cytotoxic T lymphocyte or natural killer cell differentiation","volume":"150","author":"Felgar R.E.","year":"1997","journal-title":"American Journal of Pathology"},{"key":"e_1_2_6_10_1","first-page":"161","article-title":"Characteristics of pro\u2010T ALL subgroups: comparison with late T\u2010ALL. The Groupe d\u2019Etude Immunologique des Leucemies","volume":"7","author":"Garand R.","year":"1993","journal-title":"Leukaemia"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(05)70192-1"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(05)70188-X"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(81)90001-1"},{"key":"e_1_2_6_14_1","first-page":"1","article-title":"Molecular basis of Fc receptor function","volume":"54","author":"Hibett M.D.","year":"1994","journal-title":"Advances in Immunology"},{"key":"e_1_2_6_15_1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1182\/blood.V71.1.123.123","article-title":"Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukaemia in adults","volume":"71","author":"Hoelzer D.","year":"1988","journal-title":"Blood"},{"key":"e_1_2_6_16_1","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1182\/blood.V89.3.980","article-title":"Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T\u2010 and null\u2010cell type and Hodgkin\u2019s disease: evidence for distinct cellular origin","volume":"89","author":"Krenacs L.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.2.685"},{"key":"e_1_2_6_18_1","first-page":"ELT26","article-title":"CD56 in T\u2010cell acute lymphoblastic leukaemia: a malignant transformation of an early myeloid\u2010lymphoid progenitor?","volume":"88","author":"Montero I.","year":"2003","journal-title":"Haematologica"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2000.00936.x"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800129"},{"key":"e_1_2_6_21_1","first-page":"1135","article-title":"CD56 and PGP expression in acute myeloid leukaemia: impact on clinical outcome","volume":"87","author":"Raspadori D.","year":"2002","journal-title":"Haematologica"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(01)00188-6"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(95)00147-6"},{"key":"e_1_2_6_24_1","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1182\/blood.V84.1.244.244","article-title":"HLA\u2010DR\u2010, CD33+, CD56+, CD16\u2010 myeloid\/natural killer cell acute leukaemia: a previously unrecognized form of acute leukaemia potentially misdiagnosed as French\u2010American\u2010British acute myeloid leukaemia\u2010M3","volume":"84","author":"Scott A.A.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.11-3-263"},{"key":"e_1_2_6_26_1","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1182\/blood.V90.6.2417","article-title":"CD7+ and CD56+ myeloid\/natural killer cell precursor acute leukaemia: a distinct hematolymphoid disease entity","volume":"90","author":"Suzuki R.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-2478(92)90144-D"},{"key":"e_1_2_6_28_1","first-page":"313","article-title":"Perforin and granzyme expression in cytotoxic T\u2010cells lymphomas","volume":"11","author":"Yamashita Y.","year":"1998","journal-title":"Modern Pathology"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2008.07457.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2008.07457.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T04:39:49Z","timestamp":1695962389000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2008.07457.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,17]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["10.1111\/j.1365-2141.2008.07457.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2008.07457.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,17]]},"assertion":[{"value":"2008-12-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}